UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial

Journal of clinical oncology, 2018-03, Vol.36 (9), p.875-883

2018

Link zum Volltext

Verfügbarkeit prüfen

Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial

Breast cancer research : BCR, 2018-10, Vol.20 (1), p.124-124, Article 124

2018

Link zum Volltext

Verfügbarkeit prüfen

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer

Journal of hematology and oncology, 2018-06, Vol.11 (1), p.80-80, Article 80

2018

Link zum Volltext

Verfügbarkeit prüfen

Aerobic and Resistance Exercise Improves Shoulder Function in Women Who Are Overweight or Obese and Have Breast Cancer: A Randomized Controlled Trial

Physical therapy, 2019-10, Vol.99 (10), p.1334-1345

2019

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women

Journal of clinical oncology, 2011-11, Vol.29 (33), p.4373-4380

2011

Link zum Volltext

Verfügbarkeit prüfen

GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (16), p.7849-7853

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women

Cancer prevention research (Philadelphia, Pa.), 2012-03, Vol.5 (3), p.393-402

2012

Link zum Volltext

Verfügbarkeit prüfen

Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib

NPJ breast cancer, 2022-02, Vol.8 (1), p.22-22, Article 22

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

BioMed research international, 2015-01, Vol.2015, p.934164-9

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase II Studies of Gemcitabine and Cisplatin in Heavily and Minimally Pretreated Metastatic Breast Cancer

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2163-2169

2009

Link zum Volltext

Verfügbarkeit prüfen

Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast

Breast cancer research and treatment, 2009-11, Vol.118 (1), p.161-168

2009

Link zum Volltext

Verfügbarkeit prüfen

Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients

Frontiers in oncology, 2013-01, Vol.3, p.298-298

2013

Link zum Volltext

Verfügbarkeit prüfen

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Journal of clinical oncology, 2003-03, Vol.21 (5), p.864-870

2003

Link zum Volltext

Verfügbarkeit prüfen

Decreasing time to initiation of inpatient chemotherapy at LAC+USC medical center utilizing an admission checklist

Journal of clinical oncology, 2019-09, Vol.37 (27_suppl), p.262-262

2019

Link zum Volltext

Verfügbarkeit prüfen

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

Breast cancer research and treatment, 2012-04, Vol.132 (2), p.653-660

2012

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen, Soy, and Lifestyle Factors in Asian American Women With Breast Cancer

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3024-3030

2007

Link zum Volltext

Verfügbarkeit prüfen

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Contraception (Stoneham), 2012-09, Vol.86 (3), p.238-243

2012

Link zum Volltext

Verfügbarkeit prüfen

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Clinical cancer research, 2007-01, Vol.13 (2), p.654-658

2007

Link zum Volltext

Verfügbarkeit prüfen

Abstract PO-276: Lazarex Cancer Foundation (LCF) financial reimbursement programs (FRP) promote equitable access and inclusion among racial/ethnic minorities in therapeutic cancer clinical trials (TCT)

Cancer epidemiology, biomarkers & prevention, 2020-12, Vol.29 (12_Supplement), p.PO-276-PO-276

2020

Link zum Volltext

Verfügbarkeit prüfen

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

The lancet oncology, 2020-04, Vol.21 (4), p.519-530

2020

Link zum Volltext

Verfügbarkeit prüfen

Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study

Breast cancer research and treatment, 2020-07, Vol.182 (2), p.451-463

2020

Link zum Volltext

Verfügbarkeit prüfen

Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention

Breast cancer research and treatment, 2018-02, Vol.168 (1), p.147-157

2018

Link zum Volltext

Verfügbarkeit prüfen

Measuring the long commute: Experiences of a multi-ethnic cohort of patients enrolled in a financial reimbursement program for cancer clinical trials

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e18568-e18568

2022

Link zum Volltext

Verfügbarkeit prüfen

Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.85-85

2020

Link zum Volltext

Verfügbarkeit prüfen

GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy

International journal of cancer, 2011-02, Vol.128 (3), p.726-731

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(114)

Publikationsform

Sprache

Englisch
(115)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(68)
Science & Technology
(68)
Humans
(60)
Female
(59)
Oncology
(53)
Adult
(41)
Middle Aged
(39)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Breast Cancer
(30)
Aged
(20)
Tumors
(18)
Gynecology. Andrology. Obstetrics
(17)
Pharmacology. Drug Treatments
(17)
Antineoplastic Agents
(14)
Mammary Gland Diseases
(14)
Breast Neoplasms - Prevention & Control
(13)
Chemotherapy
(13)
Breast Neoplasms - Pathology
(11)
Breast Neoplasms - Therapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial

Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial

Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer

Aerobic and Resistance Exercise Improves Shoulder Function in Women Who Are Overweight or Obese and Have Breast Cancer: A Randomized Controlled Trial

Characteristics of Triple-Negative Breast Cancer in Patients With a BRCA1 Mutation: Results From a Population-Based Study of Young Women

GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer

Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women

Disease characterization in liquid biopsy from HER2-mutated, non-amplified metastatic breast cancer patients treated with neratinib

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

Phase II Studies of Gemcitabine and Cisplatin in Heavily and Minimally Pretreated Metastatic Breast Cancer

Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast

Biological effects of green tea capsule supplementation in pre-surgery postmenopausal breast cancer patients

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Decreasing time to initiation of inpatient chemotherapy at LAC+USC medical center utilizing an admission checklist

Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

Tamoxifen, Soy, and Lifestyle Factors in Asian American Women With Breast Cancer

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Abstract PO-276: Lazarex Cancer Foundation (LCF) financial reimbursement programs (FRP) promote equitable access and inclusion among racial/ethnic minorities in therapeutic cancer clinical trials (TCT)

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study

Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention

Measuring the long commute: Experiences of a multi-ethnic cohort of patients enrolled in a financial reimbursement program for cancer clinical trials

Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study

GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy

Suchergebnisse filtern